Press Releases from BiopharmaVantage (3 total)
Pharma valuation expert, BiopharmaVantage advises on the valuation of a pharmace …
Pharma and Biotech valuation expert, BiopharmaVantage is delighted to announce that it has advised on the valuation of an early-stage pharmaceutical company (the client) seeking investment. The early-stage company utilizes a de-risked platform for devising therapeutics for various indications, and the lead asset is an intervention for the treatment of COVID 19 patients.
The engagement lead at BiopharmaVantage commented- ‘COVID has significantly affected the products portfolio of pharmaceutical companies. The industry…
Demystifying pharma COGS competitive intelligence
COGS, aka the cost of goods sold, is one of the key intelligence questions that frequently emerges in the pharma competitive intelligence engagements. BiopharmaVantage, the specialist pharma competitive intelligence firm, describes the issues with COGS so that end-users leverage such intelligence judiciously in their pharma intelligence collection exercises. These include:
• Understanding of the meaning of COGS
• Impact of method of accounts
• Impact of accounting policies
• Global footprint of pharma value chain
• Learn from the evolving…
Maximizing ROI of Pharma Competitive Intelligence
Maximizing ROI of pharmaceutical competitive intelligence engagements is vital for a variety of reasons. BiopharmaVantage, the specialist pharma competitive intelligence firm describes the key success factors that users need to focus on in order to maximize the ROI of engagements. The firm recommends the usage of the following multi-factor framework:
Aren’t they well known?
Collectors become defenders
Consulting firm aspirants
Procuring non-core services of suppliers
Learn from the evolving market
An agency with ex-pharma employees
Intelligence collection…
